Adenocarcinoma of the Lung
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Lung.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
A recruiting clinical trial evaluating biomarkers for diagnosing lung cancer, predicting post-treatment recurrence risk, and guiding long-te…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Prospective Data Collection Initiative on Thoracic Malignancies
A prospective data collection initiative on thoracic malignancies sponsored by the Dutch Society of Physicians for Pulmonology and Tuberculo…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [NA]
This clinical trial update outlines a study of image-guided hypofractionated radiation therapy with a stereotactic body radiation therapy bo…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features [Phase 3]
Phase III randomized trial evaluating adjuvant datopotamab deruxtecan (Dato-DXd) in combination with rilvegostomig or rilvegostomig monother…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
A clinical trial is exploring AI-based multimodal data to predict efficacy of targeted therapies in EGFR-mutant non-small cell lung cancer, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial [Phase 2]
This entry announces a Phase II randomized, double-blind trial of RMT in combination with Durvalumab and chemotherapy in untreated non-small…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma [Phase 3]
Phase 3 clinical trial evaluating SI-B001 in combination with docetaxel for adenocarcinoma of the lung and squamous cell carcinoma of the lu…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery [NA]
This clinical trial update indicates ongoing recruitment for a study evaluating bioimpedance analysis as part of perioperative assessment in…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Lung Cancer Mutation Consortium Protocol
A completed update on the Lung Cancer Mutation Consortium protocol, describing its study design and the condition of interest (adenocarcinom…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy [Phase 1]
A Phase 1 clinical trial evaluating reinforced versus non-reinforced staple lines in fissureless lobectomy for lung cancer, currently not re…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
An ongoing clinical study is investigating therapeutic resistance and clonal evolution in non-small cell lung cancer patients treated with i…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment [Phase 1, Phase 2]
Completed Phase 1/2 trial evaluating the combination of rigosertib and nivolumab in KRAS-positive non-small cell lung cancer patients who pr…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology [Phase 1, Phase 2]
Phase 1/2 trial evaluating the feasibility and safety of nintedanib in combination with nivolumab in pretreated advanced or metastatic adeno…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer [Phase 2]
Phase 2 trial update of crizotinib in ROS1-translocated lung cancer (EU CROSS) completed.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers [Phase 2]
Phase 2 trial evaluating ponatinib in lung cancer patients preselected by predictive biomarkers; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas [Phase 1, Phase 2]
Clinical trial update for ctDNA-MRD based adjuvant targeted therapy in EGFR-positive stage I lung adenocarcinoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung [Phase 2]
Phase 2 trial assessing adjuvant pemetrexed plus cisplatin for lung adenocarcinoma reports efficacy and safety findings.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer [Phase 1, Phase 2]
A clinical trial update on targeted stem cells expressing TRAIL for lung cancer (adenocarcinoma of the lung) in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung [Phase 2]
Phase 2 trial assessing safety and efficacy of Farletuzumab in adenocarcinoma of the lung has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing whether adding metformin hydrochloride to chemotherapy and radiation improves outcomes for Stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor [Phase 2]
Phase 2 trial evaluating single agent chemotherapy with or without nivolumab in advanced NSCLC patients with primary resistance to prior PD-…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung [Phase 2]
Phase 2 study assessing safety and activity of lenvatinib (E7080) in KIF5B-RET–positive adenocarcinoma of the lung has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma [Phase 1, Phase 2]
Phase 1/2 trial evaluating SS1P with pentostatin and cyclophosphamide for mesothelioma and related cancers has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases [Phase 3]
A Phase 3 trial in non-squamous non-small cell lung cancer with brain metastases has been terminated; no results are provided in this update…